249 related articles for article (PubMed ID: 27776266)
1. Aβ vaccination in combination with behavioral enrichment in aged beagles: effects on cognition, Aβ, and microhemorrhages.
Davis PR; Giannini G; Rudolph K; Calloway N; Royer CM; Beckett TL; Murphy MP; Bresch F; Pagani D; Platt T; Wang X; Donovan AS; Sudduth TL; Lou W; Abner E; Kryscio R; Wilcock DM; Barrett EG; Head E
Neurobiol Aging; 2017 Jan; 49():86-99. PubMed ID: 27776266
[TBL] [Abstract][Full Text] [Related]
2. Vaccination of Alzheimer's model mice with Abeta derivative in alum adjuvant reduces Abeta burden without microhemorrhages.
Asuni AA; Boutajangout A; Scholtzova H; Knudsen E; Li YS; Quartermain D; Frangione B; Wisniewski T; Sigurdsson EM
Eur J Neurosci; 2006 Nov; 24(9):2530-42. PubMed ID: 17100841
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic Vaccine Based on Pyroglutamate-3 Amyloid β Generates Strong Antibody Response and Rescues Cognitive Decline in Alzheimer's Disease Model Mice.
Li G; Hu ZW; Chen PG; Sun ZY; Chen YX; Zhao YF; Li YM
ACS Chem Neurosci; 2017 Mar; 8(3):454-459. PubMed ID: 28292186
[TBL] [Abstract][Full Text] [Related]
4. Strikingly reduced amyloid burden and improved behavioral performance in Alzheimer's disease mice immunized with recombinant chimeric vaccines by hexavalent foldable Aβ₁₋₁₅ fused to toxin-derived carrier proteins.
Yu YZ; Wang WB; Chen A; Chang Q; Liu S; Zhao M; Wang S; Qiu WY; Pang XB; Xu Q; Sun ZW
J Alzheimers Dis; 2014; 41(1):243-60. PubMed ID: 24625800
[TBL] [Abstract][Full Text] [Related]
5. A two-year study with fibrillar beta-amyloid (Abeta) immunization in aged canines: effects on cognitive function and brain Abeta.
Head E; Pop V; Vasilevko V; Hill M; Saing T; Sarsoza F; Nistor M; Christie LA; Milton S; Glabe C; Barrett E; Cribbs D
J Neurosci; 2008 Apr; 28(14):3555-66. PubMed ID: 18385314
[TBL] [Abstract][Full Text] [Related]
6. Improved synaptic and cognitive function in aged 3 × Tg-AD mice with reduced amyloid-β after immunotherapy with a novel recombinant 6Aβ15-TF chimeric vaccine.
Yu YZ; Li QL; Wang HC; Liu S; Pang XB; Xu Q; Zhou XW; Huang PT
Clin Immunol; 2018 Aug; 193():12-23. PubMed ID: 29803820
[TBL] [Abstract][Full Text] [Related]
7. Lifelong immunization with human beta-amyloid (1-42) protects Alzheimer's transgenic mice against cognitive impairment throughout aging.
Jensen MT; Mottin MD; Cracchiolo JR; Leighty RE; Arendash GW
Neuroscience; 2005; 130(3):667-84. PubMed ID: 15590151
[TBL] [Abstract][Full Text] [Related]
8. Consequence of Abeta immunization on the vasculature of human Alzheimer's disease brain.
Boche D; Zotova E; Weller RO; Love S; Neal JW; Pickering RM; Wilkinson D; Holmes C; Nicoll JA
Brain; 2008 Dec; 131(Pt 12):3299-310. PubMed ID: 18953056
[TBL] [Abstract][Full Text] [Related]
9. Young to Middle-Aged Dogs with High Amyloid-β Levels in Cerebrospinal Fluid are Impaired on Learning in Standard Cognition tests.
Borghys H; Van Broeck B; Dhuyvetter D; Jacobs T; de Waepenaert K; Erkens T; Brooks M; Thevarkunnel S; Araujo JA
J Alzheimers Dis; 2017; 56(2):763-774. PubMed ID: 28035921
[TBL] [Abstract][Full Text] [Related]
10. The canine (dog) model of human aging and disease: dietary, environmental and immunotherapy approaches.
Cotman CW; Head E
J Alzheimers Dis; 2008 Dec; 15(4):685-707. PubMed ID: 19096165
[TBL] [Abstract][Full Text] [Related]
11. [Aβ42 gene vaccine for prevention and treatment of Alzheimer's disease].
Rosenberg RN
Rinsho Shinkeigaku; 2010 Nov; 50(11):838. PubMed ID: 21921464
[No Abstract] [Full Text] [Related]
12. Effective DNA epitope chimeric vaccines for Alzheimer's disease using a toxin-derived carrier protein as a molecular adjuvant.
Yu YZ; Wang S; Bai JY; Zhao M; Chen A; Wang WB; Chang Q; Liu S; Qiu WY; Pang XB; Xu Q; Sun ZW
Clin Immunol; 2013 Oct; 149(1):11-24. PubMed ID: 23886550
[TBL] [Abstract][Full Text] [Related]
13. Combined treatment of amyloid-β₁₋₄₂-stimulated bone marrow-derived dendritic cells plus splenocytes from young mice prevents the development of Alzheimer's disease in APPswe/PSENldE9 mice.
Wang F; Liu H; Shen X; Ao H; Moore N; Gao L; Chen L; Hu H; Ma H; Yang Z; Zhai C; Qin J; Zhou G; Peng Y; Feng X; Li R; Liang C
Neurobiol Aging; 2015 Jan; 36(1):111-22. PubMed ID: 25085784
[TBL] [Abstract][Full Text] [Related]
14. Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.
Shin MK; Kim HG; Baek SH; Jung WR; Park DI; Park JS; Jo DG; Kim KL
Neurobiol Aging; 2014 May; 35(5):990-1001. PubMed ID: 24268884
[TBL] [Abstract][Full Text] [Related]
15. Mucosal immunotherapy in an Alzheimer mouse model by recombinant Sendai virus vector carrying Aβ1-43/IL-10 cDNA.
Hara H; Mouri A; Yonemitsu Y; Nabeshima T; Tabira T
Vaccine; 2011 Oct; 29(43):7474-82. PubMed ID: 21803105
[TBL] [Abstract][Full Text] [Related]
16. An anti-pyroglutamate-3 Aβ vaccine reduces plaques and improves cognition in APPswe/PS1ΔE9 mice.
Frost JL; Liu B; Rahfeld JU; Kleinschmidt M; O'Nuallain B; Le KX; Lues I; Caldarone BJ; Schilling S; Demuth HU; Lemere CA
Neurobiol Aging; 2015 Dec; 36(12):3187-3199. PubMed ID: 26453001
[TBL] [Abstract][Full Text] [Related]
17. Rapid improvement of canine cognitive dysfunction with immunotherapy designed for Alzheimer's disease.
Bosch MN; Gimeno-Bayón J; Rodríguez MJ; Pugliese M; Mahy N
Curr Alzheimer Res; 2013 Jun; 10(5):482-93. PubMed ID: 23566345
[TBL] [Abstract][Full Text] [Related]
18. Brain-derived neurotrophic factor and TrkB expression in the "oldest-old," the 90+ Study: correlation with cognitive status and levels of soluble amyloid-beta.
Michalski B; Corrada MM; Kawas CH; Fahnestock M
Neurobiol Aging; 2015 Dec; 36(12):3130-3139. PubMed ID: 26410307
[TBL] [Abstract][Full Text] [Related]
19. A novel monoclonal antibody against the N-terminus of Aβ1-42 reduces plaques and improves cognition in a mouse model of Alzheimer's disease.
Xing HY; Li B; Peng D; Wang CY; Wang GY; Li P; Le YY; Wang JM; Ye G; Chen JH
PLoS One; 2017; 12(6):e0180076. PubMed ID: 28662102
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapy in a natural model of Abeta pathogenesis: the aging beagle.
Vasilevko V; Head E
CNS Neurol Disord Drug Targets; 2009 Apr; 8(2):98-113. PubMed ID: 19355931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
